Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer.

Merajver SD, Petty EM.

Clin Lab Med. 1996 Mar;16(1):139-67.

PMID:
8867588
2.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
3.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

4.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
5.
6.

Ethics of predictive DNA-testing for hereditary breast and ovarian cancer.

de Wert G.

Patient Educ Couns. 1998 Sep;35(1):43-52. Review.

PMID:
9832896
7.

[Hereditary breast and ovarian cancer syndrome].

Plevová P, Novotný J, Petráková K, Palácová M, Kalábová R, Schneiderová M, Foretová L.

Klin Onkol. 2009;22 Suppl:S8-11. Review. Czech. No abstract available.

PMID:
19764385
8.

Mutations of BRCA genes in hereditary breast and ovarian cancer.

Radice P.

J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):9-12. Review.

PMID:
12585647
9.

Identifying and managing hereditary risk of breast and ovarian cancer.

Frank TS, Critchfield GC.

Clin Perinatol. 2001 Jun;28(2):395-406. Review.

PMID:
11499060
10.

BRCA1, BRCA2, BRCA3 ... a myriad of breast cancer genes.

Bishop DT.

Eur J Cancer. 1994;30A(12):1738-9. Review. No abstract available.

PMID:
7880596
11.

Genetic susceptibility to breast and ovarian cancer.

Skolnick MH, Frank T, Shattuck-Eidens D, Tavtigian S.

Pathol Biol (Paris). 1997 Mar;45(3):245-9. Review.

PMID:
9296070
12.

Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.

Prucka SK, McIlvried DE, Korf BR.

Med Princ Pract. 2008;17(3):173-89. doi: 10.1159/000117790. Epub 2008 Apr 10. Review.

13.

[Molecular genetics of hereditary breast carcinoma].

Hampl M, Chang-Claude J, Schwarz P, Saeger HD, Schackert HK.

Zentralbl Chir. 1997;122(2):67-73. Review. German.

PMID:
9173760
14.

[Tumor risk consultation for predisposed women from high risk cancer families].

Beckmann MW, Niederacher D, Bodden-Heidrich R, Goecke TO, Kuschel B, Achnoula M, Aba F, Schnürch HG, Bender HG.

Praxis (Bern 1994). 1998 Apr 8;87(15):511-5. Review. German.

PMID:
9608246
15.

Implication of BRCA1 gene in breast cancer.

Kachhap SK, Ghosh SN.

Indian J Exp Biol. 2001 May;39(5):391-400. Review.

PMID:
11510120
16.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force..

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
16144895
17.

Genetic testing by cancer site: breast.

Shannon KM, Chittenden A.

Cancer J. 2012 Jul-Aug;18(4):310-9. doi: 10.1097/PPO.0b013e318260946f. Review.

PMID:
22846731
18.

Genetic predisposition syndromes and their management.

Euhus DM, Robinson L.

Surg Clin North Am. 2013 Apr;93(2):341-62. doi: 10.1016/j.suc.2013.01.005. Epub 2013 Feb 11. Review.

PMID:
23464690
19.

Identification of the BRCA1 breast cancer gene and its clinical implications.

Kamb A, Skolnick MH.

Important Adv Oncol. 1996:23-35. Review. No abstract available.

PMID:
8791126
20.

Tumor suppressor genes and their alterations in breast cancer.

Lee EY.

Semin Cancer Biol. 1995 Jun;6(3):119-25. Review.

PMID:
7495979

Supplemental Content

Support Center